π
|
Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study.
15 auth.
D. Skarlos,
E. Samantas,
P. Kosmidis,
G. Fountzilas,
M. Angelidou,
P. Palamidas,
N. Mylonakis,
A. Provata,
E. Papadakis,
G. Klouvas,
...
D. Theocharis,
E. Panousaki,
E. Boleti,
G. Sphakianoudis,
N. Pavlidis
|
7 |
1994 |
7 π
|
π
|
Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study.
10 auth.
D. Pectasides,
M. Pectasides,
Dimitrios Farmakis,
G. Aravantinos,
Maria Nikolaou,
M. Koumpou,
...
A. Gaglia,
V. Kostopoulou,
N. Mylonakis,
D. Skarlos
|
6 |
2004 |
6 π
|
π
|
Comparison of docetaxel and docetaxel-irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial.
11 auth.
D. Pectasides,
M. Pectasides,
D. Farmakis,
V. Kostopoulou,
Michail Nikolaou,
A. Gaglia,
...
M. Koumpou,
N. Mylonakis,
N. Xiros,
T. Economopoulos,
S. Raptis
|
6 |
2005 |
6 π
|
π
|
Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG).
11 auth.
P. Kosmidis,
N. Mylonakis,
D. Skarlos,
E. Samantas,
Meletios-Athanassios Dimopoulos,
Constantine S. Papadimitriou,
...
C. Kalophonos,
N. Pavlidis,
C. Nikolaidis,
C. Papaconstantinou,
G. Fountzilas
|
6 |
2000 |
6 π
|
π
|
A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancer.
11 auth.
N. Tsavaris,
K. Tentas,
P. Kosmidis,
N. Mylonakis,
N. Sakelaropoulos,
C. Kosmas,
...
B. Lisaios,
A. Soumilas,
D. Mandrekas,
A. Tsetis,
C. Klonaris
|
6 |
1996 |
6 π
|
π
|
Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach
7 auth.
N. Tsavaris,
P. Komitsopoulou,
P. Karagiaouris,
P. Loukatou,
I. Tzannou,
N. Mylonakis,
...
P. Kosmidis
|
5 |
2004 |
5 π
|
π
|
Conservative approach to the treatment of chemotherapy-induced extravasation.
11 auth.
Nicolas Tsavaris,
P. Karagiaouris,
I. Tzannou,
P. Komitsopoulou,
C. Bacoyiannis,
A. Karabellis,
...
V. Papanicolaou,
N. Mylonakis,
N. Karvounis,
A. Zoannou,
P. Kosmidis
|
5 |
1990 |
5 π
|
π
|
Paclitaxel and carboplatin in inoperable non-small-cell lung cancer: a phase II study.
8 auth.
P. Kosmidis,
N. Mylonakis,
G. Fountzilas,
E. Samantas,
A. Athanasiadis,
Eleni Andreopoulou,
...
N. Pavlidis,
D. Skarlos
|
5 |
1997 |
5 π
|
π
|
Evaluation of the paclitaxelβifosfamideβcisplatin (TIP) combination in relapsed and/or metastatic cervical cancer
11 auth.
C. Kosmas,
N. Mylonakis,
G. Tsakonas,
G. Vorgias,
N. Karvounis,
N. Tsavaris,
...
T. Daladimos,
N. Kalinoglou,
N. Malamos,
T. Akrivos,
A. Karabelis
|
5 |
2009 |
5 π
|